| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $15.30B | -8.3% |
| R&D Expense | $42.0M | -6.7% |
| SG&A Expense | $2.52B | -1.0% |
| Operating Income | $175.3M | -91.4% |
| Interest Expense | $38.9M | +70.7% |
| Pre-tax Income | -$1.50B | -148.3% |
| Income Tax | -$371.7M | -150.8% |
| Net Income | -$1.13B | -147.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $373.6M | -79.1% |
| Short-term Investments | $8.1M | -99.0% |
| Accounts Receivable | $890.3M | -6.7% |
| Inventory | $497.1M | -1.1% |
| Current Assets | $2.34B | -49.2% |
| Total Assets | $51.41B | -2.3% |
| Current Liabilities | $7.59B | +26.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.00B | -35.4% |
| Capital Expenditures | $2.83B | +3.7% |
| Investing Cash Flow | -$3.11B | +64.6% |
| Financing Cash Flow | -$273.5M | -42.9% |
| Free Cash Flow | -$831.8M | -328.0% |
| Total Liabilities |
| $34.18B |
| -0.0% |
| Stockholders' Equity | $16.79B | -6.4% |